In vitro activities of the ketolide HMR 3647 against recent gram-positive clinical isolates and Haemophilus influenzae
- PMID: 9687424
- PMCID: PMC105887
- DOI: 10.1128/AAC.42.8.2138
In vitro activities of the ketolide HMR 3647 against recent gram-positive clinical isolates and Haemophilus influenzae
Abstract
The ketolide HMR 3647 (previously RU 66647) was evaluated against 2, 563 recent clinical isolates of gram-positive pathogens and 200 Haemophilus influenzae isolates. HMR 3647 was active against macrolide-resistant streptococci, including pneumococci, but was not active against macrolide- or lincosamide-resistant staphylococci. Against H. influenzae, the potency of HMR 3647 was similar to that of azithromycin.
References
-
- Agouridas C, Bonnefoy A, Chantot J F. Program and Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C: American Society for Microbiology; 1994. Ketolides, a new semi-synthetic class of macrolides: in-vitro and in-vivo antibacterial activities, abstr. F168; p. 227.
-
- Barry A L, Fuchs P C, Brown S D. Macrolide resistance among Streptococcus pneumoniae and Streptococcus pyogenes isolates from outpatients in the USA. J Antimicrob Chemother. 1997;40:139–140. - PubMed
-
- Barry A L, Fuchs P C, Brown S D. In vitro activity of the new ketolide HMR3004 compared to an azalide and macrolides against Streptococcus pneumoniae and Haemophilus influenzae. Eur J Clin Microbiol Infect Dis. 1997;16:767–769. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
